124 related articles for article (PubMed ID: 22853993)
1. A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulation.
Radi M; Evensen L; Dreassi E; Zamperini C; Caporicci M; Falchi F; Musumeci F; Schenone S; Lorens JB; Botta M
Bioorg Med Chem Lett; 2012 Sep; 22(17):5579-83. PubMed ID: 22853993
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
3. In-silico fragment-based identification of novel angiogenesis inhibitors.
Dakshanamurthy S; Kim M; Brown ML; Byers SW
Bioorg Med Chem Lett; 2007 Aug; 17(16):4551-6. PubMed ID: 17591441
[TBL] [Abstract][Full Text] [Related]
4. Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay.
Cross LM; Cook MA; Lin S; Chen JN; Rubinstein AL
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):911-2. PubMed ID: 12740225
[No Abstract] [Full Text] [Related]
5. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
6. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
7. Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
Nicoli S; Ribatti D; Cotelli F; Presta M
Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396
[TBL] [Abstract][Full Text] [Related]
8. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM
Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466
[TBL] [Abstract][Full Text] [Related]
9. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
Li X; Wang X; Ye H; Peng A; Chen L
Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
[TBL] [Abstract][Full Text] [Related]
10. The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety.
Nkembo AT; Ntantie E; Salako OO; Amissah F; Poku RA; Latinwo LM; Lamango NS
Oncotarget; 2016 Oct; 7(42):68194-68205. PubMed ID: 27626690
[TBL] [Abstract][Full Text] [Related]
11. Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathway.
Wu Y; He L; Zhang L; Chen J; Yi Z; Zhang J; Liu M; Pang X
J Pharmacol Exp Ther; 2011 Nov; 339(2):403-11. PubMed ID: 21828260
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol derivative, trans-3,5,4'-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation.
Alex D; Leong EC; Zhang ZJ; Yan GT; Cheng SH; Leong CW; Li ZH; Lam KH; Chan SW; Lee SM
J Cell Biochem; 2010 Feb; 109(2):339-46. PubMed ID: 20014068
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo anti-angiogenic activity of girinimbine isolated from Murraya koenigii.
Iman V; Karimian H; Mohan S; Hobani YH; Noordin MI; Mustafa MR; Noor SM
Drug Des Devel Ther; 2015; 9():1281-92. PubMed ID: 25767375
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic cancer drug using the zebrafish model.
Santoro MM
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1846-53. PubMed ID: 24903092
[TBL] [Abstract][Full Text] [Related]
15. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
[TBL] [Abstract][Full Text] [Related]
16. Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.
La DS; Belzile J; Bready JV; Coxon A; DeMelfi T; Doerr N; Estrada J; Flynn JC; Flynn SR; Graceffa RF; Harriman SP; Larrow JF; Long AM; Martin MW; Morrison MJ; Patel VF; Roveto PM; Wang L; Weiss MM; Whittington DA; Teffera Y; Zhao Z; Polverino AJ; Harmange JC
J Med Chem; 2008 Mar; 51(6):1695-705. PubMed ID: 18311900
[TBL] [Abstract][Full Text] [Related]
17. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo.
Hong SJ; Wan JB; Zhang Y; Hu G; Lin HC; Seto SW; Kwan YW; Lin ZX; Wang YT; Lee SM
Phytother Res; 2009 May; 23(5):677-86. PubMed ID: 19107746
[TBL] [Abstract][Full Text] [Related]
19. Identification of noreremophilane-based inhibitors of angiogenesis using zebrafish assays.
Muthukumarasamy KM; Handore KL; Kakade DN; Shinde MV; Ranjan S; Kumar N; Sehrawat S; Sachidanandan C; Reddy DS
Org Biomol Chem; 2016 Feb; 14(5):1569-78. PubMed ID: 26483278
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor and anti-angiogenic effects of Macrothelypteris viridifrons and its constituents by HPLC-DAD/MS analysis.
Wei A; Zhou D; Ruan J; Cai Y; Xiong C; Wu G
J Ethnopharmacol; 2012 Jan; 139(2):373-80. PubMed ID: 22123201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]